© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
August 08, 2022
Oteseconazole is a treatment option for those living with a previously unmet medical need.
March 02, 2022
Molnupiravir is an oral antiviral for the treatment of mild to moderate COVID-19 in adults at high risk of severe disease.
February 04, 2022
Pfizer received an emergency use authorization (EUA) for Paxlovid, an oral pill for the treatment of mild to moderate COVID-19 in certain adult and pediatric populations.
December 15, 2021
On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.